Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angiogenesis-inhibitors for Metastatic Thyroid Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Immunotherapy_for_idiopathic_lumbosacral_plexopathy:_Cochrane_systematic_review. Accessed 29 March 2024.
Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Immunotherapy_for_idiopathic_lumbosacral_plexopathy:_Cochrane_systematic_review. Accessed March 29, 2024.
Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Immunotherapy_for_idiopathic_lumbosacral_plexopathy:_Cochrane_systematic_review
Angiogenesis-inhibitors for Metastatic Thyroid Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Immunotherapy_for_idiopathic_lumbosacral_plexopathy:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
ID - 436841
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436841/all/Immunotherapy_for_idiopathic_lumbosacral_plexopathy:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -